Treatment of Conjunctival Keratoacanthoma with Topical Interferon-alpha2b

Conjunctival keratoacanthoma is a rare disease which is believed to be a low-grade form of squamous cell carcinoma (SCC). Although conjunctival keratoacanthoma was primarily described almost 60 years ago, only few cases have been described in the English literature and its diagnosis and treatment guidelines are still controversial. Almost all suggested treatment options have been surgical methods and non-invasive methods have rarely been examined in treatment of this disease. Here we report an interesting case of conjunctival keratoacanthoma which was treated with topical Interferon-alpha2b.